AIDS

1. TAHLIL KM, Pettifor AE, Edwards JK, Tang W, et al
   Uptake of facility-based HIV testing among adolescents and young adults in Nigeria.
   AIDS. 2025 Nov 12. doi: 10.1097/QAD.0000000000004393.
   

   >> Share

   
   
2. MALAMA K, Parker R, Wall KM, Kilembe W, et al
   HIV incidence and risk factors for seroconversion among female sex workers and single mothers in a 10-year prospective cohort.
   AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004403.
   

   >> Share

   
   
3. DIGGS MR, Chu SM, Fitch KV, Olefsky M, et al
   Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial.
   AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004401.
   

   >> Share

   
   
4. ZHU X, Patel EU, Berry SA, Lucas GM, et al
   Hospital readmissions among adults with chronic kidney disease by HIV status in the United States.
   AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004397.
   

   >> Share

   
   
5. KNIGHT J, Ma H, Sithole B, Khumalo L, et al
   Evaluating the impact of achieving cascade equality in Eswatini: a modelling study on the prevention impacts of antiretroviral therapy.
   AIDS. 2025 Nov 11. doi: 10.1097/QAD.0000000000004400.
   

   >> Share

   
   
6. SHIINO T, Chikata T, Hayashida T, Tran LK, et al
   Epidemiological Links of HIV-1 CRF01_AE among Men Who Have Sex with Men in Northern Vietnam and Japan.
   AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004406.
   

   >> Share

   
   
7. OKHAGBUZO MI, Njuguna I, King'e M, Moraa H, et al
   Lower working memory and processing speed among children and youth exposed to HIV.
   AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004402.
   

   >> Share

   
   
8. LI QH, Zhao J, Hu SP, Wang FX, et al
   A novel second-generation HIV-1 circulating recombinant form (CRF183_0107) identified among men who have sex with men in China.
   AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004404.
   

   >> Share

   
   

   
   Am J Epidemiol

9. WESTMORELAND DA, Ray MA, Sultana S, Bleasdale J, et al
   Implementing and retaining a large-scale technology-mediated cohort to study HIV incidence and PrEP uptake among vulnerable cisgender men as well as transgender individuals in the U.S., the Together 5,000 cohort.
   Am J Epidemiol. 2025 Nov 12:kwaf250. doi: 10.1093.
   

   >> Share

   
   

   
   Clin Infect Dis

10. CHUNG JR, Price AM, Zimmerman RK, Moehling Geffel K, et al
    Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 season.
    Clin Infect Dis. 2025 Jan 6:ciae658. doi: 10.1093.
    

    >> Share

    
    
11. TOY M, Hutton D, Teshale E, Thompson WW, et al
    Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States.
    Clin Infect Dis. 2025 Apr 8:ciaf181. doi: 10.1093.
    

    >> Share

    
    
12. CRUM N
    Let's Get It Started: Early ART after HIV Acquisition Reduces Non-AIDS-Defining Malignancies.
    Clin Infect Dis. 2025 Nov 5:ciaf596. doi: 10.1093.
    

    >> Share

    
    
13. VAN DER WULP IAJ, Wit FW, Jongen VW, Brinkman K, et al
    Earlier initiation of treatment following HIV acquisition reduces non-AIDS-defining malignancy risk.
    Clin Infect Dis. 2025 Nov 5:ciaf595. doi: 10.1093.
    

    >> Share

    
    
14. KENYON C
    Screening for anal cancer is associated with real harms and questionable benefits.
    Clin Infect Dis. 2025 Nov 8:ciaf613. doi: 10.1093.
    

    >> Share

    
    
15. BERCOT B, Assoumou L, Camelena F, Voitichouk C, et al
    Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.
    Clin Infect Dis. 2025 Nov 10:ciaf591. doi: 10.1093.
    

    >> Share

    
    
16. CARRATALA CASTRO L, Munguambe S, Kay A, Ssengooba W, et al
    Estimating the Accuracy and Additionality of TB-LAM to Diagnose TB in Children Without HIV (AccuLAM).
    Clin Infect Dis. 2025 Nov 10:ciaf525. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

17. WHITLOCK G, Gedela K
    Who's missing from London's HIV prevention response?
    HIV Med. 2025 Nov 7. doi: 10.1111/hiv.70141.
    

    >> Share

    
    
18. KNOX C, Wright J, Levett T
    A cross-sectional comparison of the use of frailty assessment tools in older people living with HIV.
    HIV Med. 2025 Nov 13. doi: 10.1111/hiv.70125.
    

    >> Share

    
    
19. MA Y, Lohman M, Brown MJ, Li Y, et al
    Temporal network analysis of comorbidities among people with HIV in South Carolina.
    HIV Med. 2025 Nov 12. doi: 10.1111/hiv.70147.
    

    >> Share

    
    
20. WALDECKER M, Taghavi K, Pasin C, Tarr PE, et al
    Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study.
    HIV Med. 2025 Nov 11. doi: 10.1111/hiv.70137.
    

    >> Share

    
    

    
    J Infect Dis

21. HANSCOM B, Marzinke MA, Li X, Donnell D, et al
    Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083.
    J Infect Dis. 2025 Nov 5:jiaf561. doi: 10.1093.
    

    >> Share

    
    
22. SELZER L, Demirdjian S, Falkard B, Li J, et al
    Resistance Analysis of Low-Level Virologic Rebound During HIV-1 Treatment with Lenacapavir and Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab.
    J Infect Dis. 2025 Nov 5:jiaf559. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

23. NASIR MW, Gao Y
    Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon.
    J Med Virol. 2025;97:e70695.
    

    >> Share

    
    
24. CASADO-FERNANDEZ G, de la Calle-Jimenez O, Armenteros I, Lemus Aguilar L, et al
    Changes in HIV-1 Reservoir Dynamics After Mpox Infection.
    J Med Virol. 2025;97:e70690.
    

    >> Share

    
    

    
    J Virol

25. JAMIESON PJ, Shen X, Abu-Shmais AA, Wasdin PT, et al
    Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.
    J Virol. 2025 Nov 10:e0125625. doi: 10.1128/jvi.01256.
    

    >> Share

    
    

    
    Lancet

26. KARIM QA
    Lessons from Africa: health diplomacy in HIV prevention.
    Lancet. 2025 Nov 4:S0140-6736(25)01976-2. doi: 10.1016/S0140-6736(25)01976.
    

    >> Share

    
    

    
    PLoS Biol

27. DENG X, Xie S, Zhou M, Yuan Q, et al
    The RNA-binding protein RBM39 scaffolds an m(6)A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation.
    PLoS Biol. 2025;23:e3003486.
    

    >> Share

    
    

    
    PLoS One

28. HOANG TH, Alvarez GG, Adermark L, Ng N, et al
    Exploring factors associated with dual tobacco smoking among people living with HIV receiving care at HIV outpatient clinics in Hanoi, Vietnam.
    PLoS One. 2025;20:e0336112.
    

    >> Share

    
    
29. GEBRETSADIK GG, Biratu AK, Bayray Kahsay A, Gessessew A, et al
    Preconception care uptake and risk factors for adverse pregnancy outcomes among pregnant women in Tigray, northern Ethiopia: A community-based cross-sectional study.
    PLoS One. 2025;20:e0336255.
    

    >> Share

    
    

    
    PLoS Pathog

30. KALDHUSDAL V, Franzen Boger M, Burgener AD, Lajoie J, et al
    The cervicovaginal microbiome associates with spatially restricted host transcriptional signatures throughout the human ectocervical epithelium and submucosa.
    PLoS Pathog. 2025;21:e1013677.
    

    >> Share

    
    
31. ZHENG WH, Lin SY, He ZL, Ni RZ, et al
    CHIP/STUB1 suppresses the transcription and latent reactivation of HIV-1 via the TRAF6-NF-kappaB-HIV-LTR axis.
    PLoS Pathog. 2025;21:e1013683.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share